Tested Applications
| Positive WB detected in | mouse skeletal muscle tissue | 
| Positive IHC detected in | human skeletal muscle tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| WB | See 3 publications below | 
| IHC | See 3 publications below | 
| CoIP | See 1 publications below | 
Product Information
55310-1-AP targets PAMR1 in WB, IHC, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat | 
| Cited Reactivity | human, mouse | 
| Host / Isotype | Rabbit / IgG | 
| Class | Polyclonal | 
| Type | Antibody | 
| Immunogen | PeptidePredict reactive species | 
| Full Name | regeneration associated muscle protease | 
| Calculated Molecular Weight | 82 kDa | 
| Observed Molecular Weight | 78-82 kDa, 67-70 kDa | 
| GenBank Accession Number | NM_015430 | 
| Gene Symbol | PAMR1 | 
| Gene ID (NCBI) | 25891 | 
| RRID | AB_11232034 | 
| Conjugate | Unconjugated | 
| Form | Liquid | 
| Purification Method | Antigen affinity purification | 
| UNIPROT ID | Q6UXH9 | 
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. | 
| Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. | 
Background Information
PAMR1,also named as RAMP, belongs to the peptidase S1 family. It may play a role in regeneration of skeletal muscle. This antibody is specific to PAMR1.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for PAMR1 antibody 55310-1-AP | Download protocol | 
| WB protocol for PAMR1 antibody 55310-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Front Oncol High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer. | ||
| J Ethnopharmacol Qizhu Anticancer Prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes | ||
| Funct Integr Genomics NEDD4 facilitates the progression of endometrial carcinoma by enhancing PAMR1 protein degradation through ubiquitination | 






